Pulse nav.journalClub Débats actifs Tendances Explorer Chercheurs

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

© Synapse Social LLC, 2026

Politique de confidentialité

August 1, 2024Open Access

Table S5 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity

Key Points

Key points are not available for this paper at this time.

Abstract

Liver microsome metabolic stability data of BR-cpd7.

Read Full Paperexternally

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Kong et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574c3d https://doi.org/https://doi.org/10.1158/1535-7163.26423422

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
2Table S3 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
3Table S3 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
4Table S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024
5Table S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity2024

Tableau S5 d'un dégradateur sélectif de FGFR1/2 avec activité antitumorale | Synapse